Wellcome Leap is built on a unique model of innovation practiced at DARPA.
For more than six decades, this model has been an uninterrupted engine of breakthrough innovation. It is not a discovery science model, but neither is it a pure application model. It sits firmly at the intersection of the two.
Work in what we call Pasteur’s Quadrant demands that we set ambitious goals that are measurable and testable. So that we’ll know if we succeeded or failed. It requires that we intersect life sciences and engineering, so that we can demonstrate advances at convincing scale — because that’s how an idea once thought impossible, is seen as possible.